Cancer Brain Tumor

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Brain Tumor Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Brain Tumor Projects
--Antisense Pharma GmbH
--Amgen Inc
--AstraZeneca Plc
--Ark Therapeutics Group plc
--DAIICHI SANKYO COMPANY, LIMITED
--BioNumerik Pharmaceuticals, Inc.
--Erimos Pharmaceuticals
--EntreMed Inc
--Genentech Inc
--Ethypharm SA
--MGI Pharma, Inc.
--Keryx Biopharmaceuticals Inc
--Oncovir, Inc
--Nippon Kayaku Co., Ltd.
--Roche Holdings Ltd
--Pharmacyclics Inc
--TransMolecular, Inc.
--Teva Pharmaceutical Industries Ltd
--YM BioSciences Inc
--Vion Pharmaceuticals Inc

--Top Companies in early stage Brain Tumor Projects
--Ariad Pharmaceuticals Inc
--Alfacell Corp
--BioNumerik Pharmaceuticals, Inc.
--AUSTRIANOVA Biotechnology GmbH
--Celgene Corporation
--BioWa, Inc.
--Cylene Pharmaceuticals, Inc.
--Cephalon Inc
--ESBATech AG
--Diffusion Pharmaceuticals LLC
--Lixte Biotechnology Holdings, Inc.
--Kyowa Hakko Kogyo Co., Ltd.
--Merck & Co Inc
--MediGene AG
--NeuroSearch A/S
--NatImmune A/S
--Targepeutics, Inc.
--Reata Pharmaceuticals, Inc.
--TransMolecular, Inc.
--Topotarget A/S

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View